Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program

Electronic Health Record-Enabled Evidence-based Smoking Cessation Quality Improvement Program

The goal of this quality improvement program is to implement, evaluate, and sustain an evidence-based smoking cessation treatment program with a population-based approach so that all patients at the Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, and satellite locations receive assessment of smoking and all smokers receive treatment support.

Study Overview

• Status: Active, not recruiting
• Conditions: Smoking Cessation
• Intervention / Treatment: Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer; Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer; Behavioral: Data Driven Feedback reports

• Study Type: Observational
• Enrollment (Actual): 1000000

Contacts and Locations

Study Locations

• United States
  • Missouri
    • Saint Louis, Missouri, United States, 63110
      • Washington University School of Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Patients 18 years of age or older

Description

Inclusion Criteria:

-Patients seen at Siteman Cancer Center, Washington University, Barnes-Jewish Hospital, BJC Healthcare, or any of the satellite locations

Exclusion Criteria:

-None

Study Plan

How is the study designed?

Design Details

• Observational Models: Ecologic or Community
• Time Perspectives: Other

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Smoking Cessation; Patients enter the program through clinic appointments or community outreach programs.; Patients will be given brief advice to quit smoking and referral options to receive evidence-based treatment through Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov dependent on the patient's preference for counseling; Patient can also be prescribed smoking cessation pharmacotherapy

Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve cessation counseling offer; Brief advise to quit smoking; Referral to Missouri/Illinois Quitlines, Smokefree.TXT, or smokefree.gov; Behavioral: ELEVATE enhancement to electronic health record (EHR) to improve smoking cessation medication offer; -Nicotine replacement therapy, varenicline, bupropion, or combination therapy (not provided by study); Behavioral: Data Driven Feedback reports; -Feedback reports will be based on data

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Clinic level percentage of patients receiving brief counseling	From 6 months pre-intervention through 6 months post-intervention
Clinic level percentage of smokers offered referral to additional counseling	From 6 months pre-intervention through 6 months post-intervention
Clinic level percentage of smokers offered medication	From 6 months pre-intervention through 6 months post-intervention

Secondary Outcome Measures

Outcome Measure	Time Frame
Clinic level percentage of patients receiving brief counseling	Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Clinic level percentage of smokers offered referral to additional counseling	Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Clinic level percentage of smokers offered medication	Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Clinic level percentage of smokers receiving smoking assessment	Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Clinic level percentage of smokers receiving cessation medication	Estimated to be 12 months pre-intervention and 12, 24, 36, and 48 months post-intervention
Number of patients who have abstained from smoking	Estimated to be 6 months post-intervention

Collaborators and Investigators

• Sponsor: Washington University School of Medicine
• Collaborators: National Cancer Institute (NCI); National Institutes of Health (NIH)
• Investigators: Principal Investigator: Li-Shiun Chen, M.D., ScD, MPH, Washington University School of Medicine

Publications and helpful links

Helpful Links

• Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
• Related Info

Study record dates

Study Major Dates

• Study Start (Actual): October 2, 2019
• Primary Completion (Actual): April 2, 2020
• Study Completion (Estimated): October 2, 2024

Study Registration Dates

• First Submitted: September 25, 2019
• First Submitted That Met QC Criteria: September 26, 2019
• First Posted (Actual): September 27, 2019

Study Record Updates

• Last Update Posted (Actual): November 29, 2023
• Last Update Submitted That Met QC Criteria: November 28, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: 89276; P30CA091842 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No